Yan-Ruide Li

1.8k total citations · 2 hit papers
51 papers, 888 citations indexed

About

Yan-Ruide Li is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Yan-Ruide Li has authored 51 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 30 papers in Immunology and 13 papers in Molecular Biology. Recurrent topics in Yan-Ruide Li's work include CAR-T cell therapy research (41 papers), Immune Cell Function and Interaction (28 papers) and T-cell and B-cell Immunology (12 papers). Yan-Ruide Li is often cited by papers focused on CAR-T cell therapy research (41 papers), Immune Cell Function and Interaction (28 papers) and T-cell and B-cell Immunology (12 papers). Yan-Ruide Li collaborates with scholars based in United States and Russia. Yan-Ruide Li's co-authors include Lili Yang, Ying Fang, Yichen Zhu, Yang Zhou, Matthew Wilson, Adam B. Kramer, Zachary Spencer Dunn, Yanqi Yu, Kuangyi Zhou and Jiaji Yu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and ACS Nano.

In The Last Decade

Yan-Ruide Li

47 papers receiving 878 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies

2025 23 citations Yan-Ruide Li, Ying Fang et al. Nature Communications profile →
In vivo CAR engineering for immunotherapy

2025 20 citations Yan-Ruide Li, Lili Yang et al. Nature reviews. Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yan-Ruide Li United States	17	586	399	249	159	69	51	888
Kyle Dyson United States	11	425 0.7×	296 0.7×	227 0.9×	220 1.4×	113 1.6×	19	796
Johanna Theruvath United States	8	390 0.7×	318 0.8×	223 0.9×	179 1.1×	96 1.4×	22	714
Eric H. Gschweng United States	13	331 0.6×	232 0.6×	363 1.5×	295 1.9×	113 1.6×	19	773
Giulia Golinelli Italy	13	357 0.6×	189 0.5×	313 1.3×	207 1.3×	109 1.6×	23	816
Sadhak Sengupta United States	14	396 0.7×	387 1.0×	278 1.1×	93 0.6×	121 1.8×	26	820
Alfonso Brito United States	6	588 1.0×	245 0.6×	225 0.9×	254 1.6×	128 1.9×	20	735
Ekaterina Friebel Switzerland	8	358 0.6×	594 1.5×	272 1.1×	110 0.7×	69 1.0×	11	987
Leah Alabanza United States	10	481 0.8×	211 0.5×	244 1.0×	178 1.1×	109 1.6×	16	730
Megan M. Davis United States	12	804 1.4×	288 0.7×	493 2.0×	230 1.4×	218 3.2×	28	1.1k
Tatsuki Ueda Japan	11	530 0.9×	282 0.7×	645 2.6×	142 0.9×	135 2.0×	24	1.0k

Countries citing papers authored by Yan-Ruide Li

Since Specialization

Citations

This map shows the geographic impact of Yan-Ruide Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan-Ruide Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan-Ruide Li more than expected).

Fields of papers citing papers by Yan-Ruide Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan-Ruide Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan-Ruide Li. The network helps show where Yan-Ruide Li may publish in the future.

Co-authorship network of co-authors of Yan-Ruide Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yan-Ruide Li. A scholar is included among the top collaborators of Yan-Ruide Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan-Ruide Li. Yan-Ruide Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Zeyang, et al.. (2026). Hemodynamics-driven magnetoelastic vascular grafts for stenosis diagnosis. Nature Biotechnology. 44(3). 406–417.

Li, Yan-Ruide, et al.. (2025). Innovative gene engineering strategies to address tumor antigen escape in cell therapy. Journal of Translational Medicine. 23(1). 1227–1227. 1 indexed citations

Fang, Ying, et al.. (2025). Protocol to generate allorejection-resistant universal CAR-NKT cells and evaluate their efficacy, mechanism of action, safety, and immunogenicity. STAR Protocols. 6(2). 103810–103810. 1 indexed citations

Zhu, Enbo, Zeyang Liu, & Yan-Ruide Li. (2025). Feeder-free advances in T cell development and therapy. 2(2). 100244–100244. 1 indexed citations

Li, Yan-Ruide, et al.. (2025). Emerging trends in clinical allogeneic CAR cell therapy. Med. 6(8). 100677–100677. 10 indexed citations

Li, Yan-Ruide, Kuangyi Zhou, Yichen Zhu, et al.. (2025). Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture. Nature Protocols. 20(5). 1352–1388. 12 indexed citations

Li, Yan-Ruide, et al.. (2025). iPSC Technology Revolutionizes CAR-T Cell Therapy for Cancer Treatment. Bioengineering. 12(1). 60–60. 8 indexed citations

Li, Yan-Ruide, et al.. (2025). In vivo CAR engineering for immunotherapy. Nature reviews. Immunology. 25(10). 725–744. 20 indexed citations breakdown →

Cho, Jae Min, Enbo Zhu, Yan-Ruide Li, et al.. (2025). Habitual Exercise Modulates Neuroimmune Interaction to Mitigate Aortic Stiffness. Circulation Research. 136(12). 1579–1594. 1 indexed citations

10.

Fang, Ying, et al.. (2025). Biological functions and therapeutic applications of human mucosal-associated invariant T cells. Journal of Biomedical Science. 32(1). 32–32. 5 indexed citations

11.

Li, Yan-Ruide, et al.. (2024). Frontiers in CAR-T cell therapy for autoimmune diseases. Trends in Pharmacological Sciences. 45(9). 839–857. 33 indexed citations

12.

Zhu, Enbo, Jiaji Yu, Yan-Ruide Li, et al.. (2024). Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for developing T cell-based therapies. Nature Nanotechnology. 19(12). 1914–1922. 12 indexed citations

13.

Li, Yan-Ruide, et al.. (2024). Managing allorejection in off-the-shelf CAR-engineered cell therapies. Molecular Therapy. 33(6). 2368–2390. 22 indexed citations

14.

Li, Yan-Ruide, et al.. (2023). Advancements in CRISPR screens for the development of cancer immunotherapy strategies. Molecular Therapy — Oncolytics. 31. 100733–100733. 10 indexed citations

15.

Wang, Shaolei, Qingyu Cui, Parinaz Abiri, et al.. (2023). A self-assembled implantable microtubular pacemaker for wireless cardiac electrotherapy. Science Advances. 9(42). eadj0540–eadj0540. 41 indexed citations

16.

Dunn, Zachary Spencer, Yanqi Yu, Kuangyi Zhou, et al.. (2023). Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering. Nature Communications. 14(1). 6942–6942. 23 indexed citations

17.

Li, Yan-Ruide, Kuangyi Zhou, Matthew Wilson, et al.. (2022). Mucosal-associated invariant T cells for cancer immunotherapy. Molecular Therapy. 31(3). 631–646. 45 indexed citations

18.

Dunn, Zachary Spencer, Yan-Ruide Li, Yanqi Yu, et al.. (2022). Minimally Invasive Preclinical Monitoring of the Peritoneal Cavity Tumor Microenvironment. Cancers. 14(7). 1775–1775. 2 indexed citations

19.

Li, Yan-Ruide, James Brown, Yanqi Yu, et al.. (2022). Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity. Cancers. 14(11). 2749–2749. 48 indexed citations

20.

Li, Yan-Ruide, Yanqi Yu, Adam B. Kramer, et al.. (2022). An Ex Vivo 3D Tumor Microenvironment-Mimicry Culture to Study TAM Modulation of Cancer Immunotherapy. Cells. 11(9). 1583–1583. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact